Meaningful Use Dropout Rate At 17 Percent | EMR and EHR
Meaningful Use Dropout Rate At 17 Percent | EMR and EHR:
'via Blog this'
Jul 02, 2013 09:10 am | By: Anne Zieger
In theory, once a provider achieves Meaningful Use and picks up their first check, one might think that they’re on board and ready to power through the program. Well, think again.
According to a piece published in HIT Consultant, 17 percent of providers who got an $18,000 EMR check in 2011 didn’t get the second $12,000 incentive payout in 2012. The stats come from a recently published analysis of the federal April EMR attestation data crunched by Wells Fargo.
What that means, in real terms, is that 17 percent of providers were able to demonstrate MU for the 90 days required in 2011 but couldn’t keep things up for the full year required for to get the second check, notes Evan Steele, CEO of EMR firm SRSsoft, who authored the article.
You’d think that providers could have demonstrated a year’s compliance, given that after 90 days they already had the needed workflows in place to support those requirements, but for nearly 20 percent of providers, it seems that simply wasn’t the case, Steele says. And this is very bad news, he suggests:
A 17% loss rate in any business is wholly unacceptable, and this failure does not portend well for the future of the EHR Incentive Program. If $12,000 proved to be insufficient motivation for physicians with meaningful use experience to meet the relatively low requirements of Stage 1 on an ongoing basis, it would be foolish to expect physicians to muster the wherewithal to meet the increasingly demanding requirements of Stage 2. The incentive for a year’s performance at that point will be a mere $4,000.
Thinking that perhaps the 17 percent dropoff trend will correct itself as time passes? Probably not. As Steele points out, another survey recently found that 14 percent of physicians who attested to Stage 1 already say that they don’t intent to attest to Stage 2.
As Steele sees it, this is evidence that we need to simplify Meaningful Use rather than making it increasingly complex, while focusing on interoperability across the entire healthcare system. In his view, if we don’t “the entire program will go down the drain.”
I don’t know if these numbers are evidence that Meaningful Use is on the skids, but a 17 percent dropoff is certainly troubling. Clearly something must be done to reach out to providers who’ve climbed off the train.
Anne Zieger is veteran healthcare consultant and analyst with 20 years of industry experience. Zieger formerly served as editor-in-chief of FierceHealthcare.com and her commentaries have appeared in dozens of international business publications, including Forbes, Business Week and Information Week. She has also contributed content to hundreds of healthcare and health IT organizations, including several Fortune 500 companies.
1 Comments:
How I became a happy woman again
With tears of joy and happiness i am giving out my testimony to all viewers on line, my problem with Stomach Cancer stage IB has caused me many pains and sadness especially in my family.
I was so afraid of loosing my life, I suffered the embarrassment of visiting
therapy hundreds of times, unfortunately they did not find a definitive solution to my problem, I cried all day and night, do I have to live my life this way? I searched all true the internet for care, I was scammed by internet fraudsters times without numbers… until a friend of mine who stays in the UK introduced me to a friend of hers who was cured of the same disease, and she introduced me to Dr Itua who cured her from Breast Cancer by this email/WhatsApp +2348149277967, drituaherbalcenter@gmail.com. I contacted him and he promised that all will be fine and I had faith.He send me his herbnal medicines through Courier servcie and i was instructed on how to drink it for three weeks to cure,I followed the instruction given to me and Today am a happy woman again. He cures all kind of diseases like__Brain cancer,Gestational trophoblastic disease,Head and neck cancer,Ovarian cancer,Hodgkin lymphoma,Herpes,,Liver cancer,Throat cancer,
Syndrome Fibrodysplasia Ossificans ProgresSclerosis,Alzheimer's disease,Chronic Diarrhea,Copd,Parkinson,Als,Adrenocortical carcinoma Infectious mononucleosis.
Intestinal cancer,Thyroid Cancer,Uterine cancer,Fibroid,Angiopathy, Ataxia,Arthritis,Amyotrophic Lateral Scoliosis,Brain Tumor,Fibromyalgia,Fluoroquinolone ToxicityBladder cancer,Hiv,Esophageal cancer,Gallbladder cancer,Kidney cancer,Hpv,Lung cancer,Melanoma,Mesothelioma,Multiple myeloma,Neuroendocrine tumors
Non-Hodgkin lymphoma,Oral cancer,Sinus cancer,Hepatitis A,B/C,Skin cancer,Soft tissue sarcoma,Spinal cancer,Stomach cancer,Vaginal cancer,Vulvar cancer,
Testicular cancer,Tach Diseases,Leukemia.
Post a Comment
Subscribe to Post Comments [Atom]
<< Home